ProfileGDS5822 / ILMN_1230882
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 60% 67% 53% 57% 65% 49% 38% 59% 61% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 128.160
GSM1276600PDAC Late Ablation Control 243.667
GSM1276601PDAC Late Ablation Control 323.953
GSM1276602PDAC Late Ablation 123.257
GSM1276603PDAC Late Ablation 239.665
GSM1276604PDAC Late Ablation 323.549
GSM1303940PDAC Late Ablation_anti-CTLA4 11838
GSM1303941PDAC Late Ablation_anti-CTLA4 234.459
GSM1303942PDAC Late Ablation_anti-CTLA4 339.261